202 related articles for article (PubMed ID: 9023716)
1. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
[TBL] [Abstract][Full Text] [Related]
2. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
3. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
4. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492
[TBL] [Abstract][Full Text] [Related]
5. Global impact of stroke.
Chalmers J
Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
[TBL] [Abstract][Full Text] [Related]
6. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
8. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
[TBL] [Abstract][Full Text] [Related]
9. [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial].
Liu LS; Gong LS; Wang W;
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):613-7. PubMed ID: 16080808
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.
PROGRESS Management Committee
J Hypertens Suppl; 1996 Sep; 14(2):S41-5; discussion S45-6. PubMed ID: 8934377
[TBL] [Abstract][Full Text] [Related]
11. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].
Lenders JW; Thien T
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939
[TBL] [Abstract][Full Text] [Related]
12. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.
Arima H; Chalmers J; Woodward M; Anderson C; Rodgers A; Davis S; Macmahon S; Neal B;
J Hypertens; 2006 Jun; 24(6):1201-8. PubMed ID: 16685221
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
14. PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected].
Neal B; MacMahon S
J Hypertens; 1995 Dec; 13(12 Pt 2):1869-73. PubMed ID: 8903669
[TBL] [Abstract][Full Text] [Related]
15. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
16. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; Macwalter R
Eur J Health Econ; 2009 Feb; 10(1):111-9. PubMed ID: 18446392
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
Tzourio C; Anderson C;
J Hypertens Suppl; 2000 May; 18(1):S21-4. PubMed ID: 10939786
[TBL] [Abstract][Full Text] [Related]
20. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]